Natural Killer Cells Therapeutics Market Projected to Double to US$ 5.4 Billion by 2028 with Robust CAGR of 13.70%
Thursday, January 11, 2024
DUBLIN , Jan. 3, 2024 /PRNewswire/ -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global natural killer cells therapeutics market is experiencing substantial growth, according to recent market analysis. In 2022, the market valuation stood at US$ 2.5 Billion, with projections indicating a surge to US$ 5.4 Billion by the year 2028. This leap reflects a Compound Annual Growth Rate (CAGR) of 13.70% during the forecast period of 2022-2028.
The burgeoning demand for natural killer (NK) cell therapeutics is primarily driven by the escalating prevalence of cancer, infectious diseases, and liver disorders worldwide. These conditions, exacerbated by lifestyle factors such as poor nutrition, sedentary habits, pollution, and use of substances like alcohol and tobacco, necessitate advanced therapeutic options. Moreover, the aging population, particularly vulnerable to cancer, is also contributing to the market expansion.
Current trends in the natural killer cells therapeutics market reveal a focus on enhancing the effectiveness of immunotherapies. Techniques include ex vivo conditioning with cytokines or drugs and the engineering of chimeric antigen receptor (CAR) NK cells. The promise of allogeneic NK cell therapies, offering robust expansion and improved targeting features, underscores an era of sustained and potent anti-cancer immune responses.
The regional analysis details market data across North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa, with insights into countries like the United States, Canada, China, Japan, India, and several others.
Key Market Players and Industry Dynamics
The competitive aspect of the market showcases an array of influential companies making strides in NK cell therapeutics, including those involved in developing innovative NK cell therapies and directed antibodies. These players are instrumental in driving forward novel treatments poised to change the paradigm of immune-mediated cancer therapies.
The extensive report seeks to answer critical questions concerning market drivers, regional market performance, and the influence of COVID-19 on market dynamics. It also provides a comprehensive account of the current state and anticipated future of the global natural killer cells therapeutics market.
Strategic Market Analysis
Thorough market segmentation has been conducted in the research, providing intricate details across various categories. The report segments the market by therapeutics, application, and end-user, alongside a geographical analysis that encompasses key regions and countries actively participating in the natural killer cells therapeutics domain.
-- Therapeutics: Includes NK Cell Therapies and NK Cell Directed
Antibodies.
-- Application: Encompasses Cancer, Gastrointestinal Diseases, and
Immunoproliferative Disorders.
-- End User: Highlights Hospitals and Research Centers and Institutes.
For more information about this report visit https://www.researchandmarkets.com/r/i6z2kb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/natural-killer-cells-therapeutics-market-projected-to-double-to-us-5-4-billion-by-2028-with-robust-cagr-of-13-70-302025474.html
SOURCE Research and Markets
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
